Literature DB >> 17041358

Central nervous system compromise in primary Sjögren's syndrome.

Juan-Manuel Anaya1, Luis A Villa, Lucas Restrepo, Jose F Molina, Rubén D Mantilla, Sergio Vargas.   

Abstract

Central nervous system (CNS) involvement in primary Sjögren's syndrome (SS) is poorly understood, and its frequency as well as its manifestations are subjects of controversy. The current study was undertaken to determine the prevalence and the clinical and immunogenetic characteristics of CNS compromise in a well defined group of patients with primary SS. In this retrospective study, patients fulfilled the European classification criteria. Among 120 patients with primary SS, 3 (2.5%) had CNS compromise (multiple sclerosis-like illness, complicated migraine, and optic neuritis with epilepsy). The CNS involvement coincided with the onset of sicca symptoms in 1 case. All 3 patients carried the human leukocyte antigen (HLA) DQB1*0303 allele and tested positive for anti-Ro antibodies, but not for anti-cardiolipin antibodies. Although rare, CNS compromise in primary SS can be the presenting manifestation of the disease in a few cases, and may be severe and varied.

Entities:  

Year:  2002        PMID: 17041358     DOI: 10.1097/00124743-200208000-00002

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  3 in total

1.  Primary Sjogren's syndrome: cognitive symptoms, mood, and cognitive performance.

Authors:  B M Segal; B Pogatchnik; E Holker; H Liu; J Sloan; N Rhodus; K L Moser
Journal:  Acta Neurol Scand       Date:  2011-06-09       Impact factor: 3.209

Review 2.  [Diagnosis and therapy of neurological manifestations of inflammatory rheumatic diseases].

Authors:  C Dejaco; T Seifert; C Duftner; M K Storch; F Fazekas; M Schirmer
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

3.  Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma.

Authors:  Michele Colaci; Giulia Cassone; Andreina Manfredi; Marco Sebastiani; Dilia Giuggioli; Clodoveo Ferri
Journal:  Case Rep Neurol Med       Date:  2014-08-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.